About Robert Essner
Robert Essner is a director at Organon &.
Form D filings name Robert Essner as an executive officer and director at Elucida Oncology.
Robert Essner reports to the SEC as a director or officer of 3 public companies, including Amicus Therapeutics (FOLD) and Wyeth (WYE).
Robert Essner first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Essner in the role, so the role may have started earlier or lasted longer.
OC
Organon & Co.
Director
2021 – 2026 · Public company (OGN)
AI
Amicus Therapeutics, Inc.
Director
2012 – 2021 · Public company (FOLD)
WY
Wyeth
Chairman of the Board
2006 – 2008 · Public company (WYE)
Key Colleagues at Startups
The people Robert Essner works with at each company, as listed on that company's latest Form D.
Elucida Oncology, Inc. · Form D/A, Aug 3, 2023
TB
Tim Boris
Director
RR
Robert Ruffolo
Director
DZ
David Zacardelli
Director
UW
Ulrich Wiesner
Director
GS
Gary Sender
Director
NM
Natalie MacDonald
Director
GG
Geno Germano
CEO and director